The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG number: 448926) The screening test is portable and can be used as an aid in diagnosis ...

Please provide your email address to receive an email when new articles are posted on . HCV screening increased after guidelines updated to screen all adults and during each pregnancy. Screening rose ...

The INSTI Hepatitis C (HCV) Antibody Test is authorized by Health Canada for immediate entry into the Canadian market The screening test is portable and can be used as an aid in diagnosis for ...

A new rapid test for hepatitis C could help identify many more patients who could be cured of the deadly disease, but its use may be limited unless insurers' reimbursement rises to cover its high cost ...

This faster polymerase chain test (PCR) allows same-day diagnosis and prompt treatment for the people affected with liver disease. This expeditious assessment aims to prevent costly and ruinous ...

Chronic hepatitis C infection affects an estimated 50 million people globally, causes approximately 242,000 deaths per year mostly due to cirrhosis and liver cancer Same-day results will help ...

bioLytical Laboratories Inc. Announces Launch of its INSTI® HCV Antibody Test for Professional Use in Australia GlobeNewswire May 19, 2024 bioLytical Laboratories Inc. announced today the immediate ...